Figure legends
Figure 1: Mapping from source database to target database generated by OHDSI’s Rabbit-In-a-Hat tool
Figure 2: Example of mapping from local concepts to concepts in the OMOP vocabulary
Figure 3: Study overview detailing criteria for inclusion and exclusion, exposure and outcomes
Figure 4: Flow diagram showing number of persons in final qualifying cohort
Figure 5. 100%, horizontally-stacked, utilization-adjusted bar charts of efficacy and safety. The vertical height of each bar is proportional to the number of patients in the cohort for 4 years of follow up. The number of patients experiencing the events of interest are represented as proportions within each bar. Event proportions are unadjusted for confounding factors.
Drug A: Apixaban, Drug B: Rivaroxaban, Drug C: Warfarin
Figure 6: Landmark analysis at six months; 100%, horizontally-stacked, utilization-adjusted bar charts of efficacy and safety limited to a follow-up period of six months. The vertical height of each bar is proportional to the number of patients in the cohort for 4 years of follow up. The number of patients experiencing the events of interest are represented as proportions within each bar. Event proportions are unadjusted for confounding factors.
Drug A: Apixaban, Drug B: Rivaroxaban, Drug C: Warfarin